16Jun
Diligence Clauses and the Management of Uncertainty in Life Sciences Agreements
In times of uncertainty and disruption, setting expectations for performance with business partners and contractual counterparties can be more complicated than ever. Companies that develop drugs, biologics and medical devices have considerable...
By:
Skadden, Arps, Slate, Meagher & Flom LLP
Related
In a decision dated 25 November 2020, the Criminal Chamber of the French “Cour de Cassation” decid...
Read More >
On January 21, 2020, Governor Murphy signed Senate Bill 3170 into law, amending the Millville Dallas...
Read More >
Seyfarth Synopsis: Seemingly overnight, the #MeToo movement emerged as a worldwide social phenomenon...
Read More >
As anticipated, on July 15, 2019, the Equal Employment Opportunity Commission (EEOC) opened its port...
Read More >
New York employers, if you employ manual workers – defined by Section 190(4) of the New York State ...
Read More >
The Small Business Administration (SBA) has designated COVID-19 as a qualifying event for the provis...
Read More >